Overview
David Schorling practices in Freiburg, Germany. Mr. Schorling is rated as an Experienced expert by MediFind in the treatment of Epilepsy in Children. His top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Becker Muscular Dystrophy, and Duchenne Muscular Dystrophy.
His clinical research consists of co-authoring 19 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Epilepsy in Children.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Primary Lateral SclerosisMr. Schorling isAdvanced. Learn about Primary Lateral Sclerosis.
- Spinal Muscular Atrophy (SMA)Mr. Schorling isAdvanced. Learn about Spinal Muscular Atrophy (SMA).
- Experienced
- Amyotonia CongenitaMr. Schorling isExperienced. Learn about Amyotonia Congenita.
- Becker Muscular DystrophyMr. Schorling isExperienced. Learn about Becker Muscular Dystrophy.
- Blood ClotsMr. Schorling isExperienced. Learn about Blood Clots.
- Cramp-Fasciculation SyndromeMr. Schorling isExperienced. Learn about Cramp-Fasciculation Syndrome.
- Deep Vein ThrombosisMr. Schorling isExperienced. Learn about Deep Vein Thrombosis.
- Duchenne Muscular DystrophyMr. Schorling isExperienced. Learn about Duchenne Muscular Dystrophy.